Similar articles

• Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al.

  Todd DJ. Todd DJ. Arthritis Rheum. 2008 Aug;58(8):2585-6; author reply 2586. doi: 10.1002/art.23738. Arthritis Rheum. 2008. PMID: 18668572 No abstract available.
• Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials.

  Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T. Takagi H, et al. Int J Cardiol. 2012 Aug 9;159(1):69-72. doi: 10.1016/j.ijcard.2012.04.077. Epub 2012 May 9. Int J Cardiol. 2012. PMID: 22575629 No abstract available.
• Atorvastatin reduces coronary plaque volume in dependence on reductions in low-density lipoprotein: a meta-analysis and meta-regression of randomized controlled trials.

  Takagi H, Umemoto T. Takagi H, et al. Int J Cardiol. 2012 May 17;157(1):114-6. doi: 10.1016/j.ijcard.2012.01.078. Epub 2012 Feb 14. Int J Cardiol. 2012. PMID: 22341753 No abstract available.
• A meta-analysis of randomized trials for effects of atorvastatin on renal function in chronic kidney disease.

  Takagi H, Umemoto T. Takagi H, et al. Int J Cardiol. 2011 Oct 20;152(2):242-4. doi: 10.1016/j.ijcard.2011.06.107. Epub 2011 Jul 20. Int J Cardiol. 2011. PMID: 21764159 Review. No abstract available.
• Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.

  Zhou Z, Rahme E, Pilote L. Zhou Z, et al. Am Heart J. 2006 Feb;151(2):273-81. doi: 10.1016/j.ahj.2005.04.003. Am Heart J. 2006. PMID: 16442888 Review.